居里 CRIS 深 沪
等待开盘 08-16 09:30:00 美东时间
1.82
+0.140
+8.33%
华盛通- 最 高1.825
- 今 开1.69
- 成交量 5.83万股
- 最 低 1.68
- 昨 收 1.68
- 总市值 1904.14万
- 52周最高 6.58
- 市盈率 静 --
- 换手率 0.56%
- 52周最低 1.02
- 委 比 -4.93%
- 总股本 1046.23万
- 历史最高 565.00
- 量 比 1.79
- 振 幅 8.63%
- 历史最低 1.02
- 每 手 1
- 风险率 1.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aptevo Unveils APVO442 Precision CD3 Bispecific For Prostate Cancer, Advancing Solid Tumor Strategy With CRIS-7 Platform
Builds on the targeted immune activation model validated by mipletamig in AML, adapted for prostate cancer.Engineered for precision T-cell activation in prostate cancer; part of Aptevo's growing CRIS-7-derived CD3
08-13 20:14
Curis Files Prospectus Supplement for Stock Offering
Curis ( ($CRIS) ) has provided an update. On August 8, 2025, Curis, Inc. announ...
08-09 05:48
Curis Q2 EPS $(0.68) Beats $(1.36) Estimate, Sales $2.75M Beat $2.64M Estimate
Curis (NASDAQ:CRIS) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(1.36) by 50 percent. This is a 66.5 percent increase over losses of $(2.03) per share from the same period
08-05 20:02
Curis Provides Second Quarter 2025 Business Update
Management to host conference call and webcast today at 8:30 a.m. ET LEXINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the develop...
08-05 20:00
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
A Peek at Curis's Future Earnings
Curis (NASDAQ:CRIS) is gearing up to announce its quarterly earnings on Tuesday...
08-05 05:04
Curis Announces $7M Securities Purchase Agreement
Curis ( ($CRIS) ) just unveiled an announcement. On July 2, 2025, Curis, Inc. a...
07-02 20:57
Curis Announces $7M Registered Direct Offering And Private Placement, Selling 1.54M Shares At $2.275 Each; The Combined Purchase Price For 1 Share And The Associated Common Warrant Is $2.275; Combined Purchase Price For 1 Pre-Funded Warrant And The Associated Common Warrant Is $2.265
Curis, Inc. ("Curis") (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that it has entered into a definitive
07-02 20:36
2024 年全球大型药企薪酬最高十位 CEO
（转自：抗体圈） 尽管在 Fierce 的 2024 年制药公司首席执行官薪酬排行榜上出现了许多熟悉的名字，但多位高管的排名发生了巨大变化，而第一名被一位黑马候...
06-18 11:23
